Krilogy Financial »

Allogene Therapeutics shares owned by Krilogy Financial

Quarter-by-quarter ownership of Allogene Therapeutics (ALLO) shares owned by Krilogy Financial from 13F filings

Historical chart of Krilogy Financial investment in Allogene Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Allogene Therapeutics held by Krilogy Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Allogene Therapeutics by Krilogy Financial

Quarter filed Position value Share count Share price at filing
2026-03-31 $40k 17k 2.37

More positions owned by Krilogy Financial

Schwab Strategic Tr Us Lcap Gr Etf (SCHG)
Pimco Etf Tr Multisector Bd (PYLD)
Schwab Strategic Tr Us Lcap Va Etf (SCHV)
Dimensional Etf Trust Us Core Eqt Mkt (DFAU)
Select Sector Spdr Tr State Street Tec (XLK)
Victory Portfolios Ii Shares Free Cash (VFLO)
Apple (AAPL)
American Centy Etf Tr Us Sml Cp Valu (AVUV)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Ishares Tr Ibonds Dec 2032 (IBTM)
Pimco Etf Tr Enhan Shrt Ma Ac (MINT)
Ishares Tr Rus Md Cp Gr Etf (IWP)
Amazon (AMZN)
Spdr Series Trust State Street Spd (SLYG)

View all positions for Krilogy Financial

Top funds holding Allogene Therapeutics

Pfizer
Tpg Gp A
BlackRock
Citadel Advisors
Vanguard Group
PRIMECAP Management Company
Patient Square Capital
Geode Capital Management
Frazier Life Sciences Management
Woodline Partners
Two Sigma Investments
Wildcat Capital Management
Two Sigma Advisers
State Street Corporation
Candriam Luxembourg S.C.A.

View all funds holding Allogene Therapeutics